REGENXBIO Inc.
RGNX
$6.72
$0.172.60%
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -227.10M | -238.81M | -241.08M | -260.15M | -263.49M |
| Total Depreciation and Amortization | 16.22M | 16.53M | 16.94M | 17.32M | 17.32M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 32.23M | 36.92M | 36.61M | 39.31M | 38.65M |
| Change in Net Operating Assets | 5.53M | 3.10M | -3.59M | 10.57M | -10.89M |
| Cash from Operations | -173.13M | -182.26M | -191.12M | -192.94M | -218.41M |
| Capital Expenditure | -2.44M | -2.48M | -3.60M | -5.70M | -9.96M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 105.88M | 99.63M | 89.14M | 146.73M | 200.90M |
| Cash from Investing | 103.45M | 97.15M | 85.55M | 141.03M | 190.94M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 133.77M | 133.94M | 139.51M | 140.06M | 8.22M |
| Repurchase of Common Stock | -910.00K | -910.00K | -910.00K | -910.00K | -419.00K |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -40.18M | -44.57M | -44.08M | -44.36M | -42.77M |
| Cash from Financing | 92.68M | 88.46M | 94.51M | 94.80M | -34.97M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 23.00M | 3.35M | -11.06M | 42.88M | -62.43M |
